Navigation Links
LA BioMed President and CEO will be named president of the American Judicature Society
Date:7/9/2009

LOS ANGELES (July 8, 2009) Carole Wagner Vallianos, Esq., president and CEO of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be inaugurated as the president of the American Judicature Society at its Annual Meeting in Chicago on July 30.

Founded in 1913, the American Judicature Society is an independent, national, nonpartisan organization of judges, lawyers and other members of the public who seek to improve the justice system. The society, which brings a public perspective to justice system issues, has the mission to secure and promote an independent and qualified judiciary and a fair system of justice.

Wagner Vallianos will take over the post from the current president, Gordon L. Doerfer of Boston, MA. Doerfer, who served 25 years on the trial and appellate courts of Massachusetts, is a mediator and arbitrator on the panel of neutrals at JAMS The Resolution Experts.

"I am honored and excited to have this opportunity to serve as president of the American Judicature Society, an organization dedicated to improving and promoting a fair system of justice," said Wagner Vallianos. "I look forward to working with my colleagues in a collaborative and coordinated effort to strengthen the American Judicature Society and the judiciary."

Wagner Vallianos became president and CEO of LA BioMed in September 2008, after serving six years on the institute's board of directors, including two years as the board's chair. She had also served as the board's treasurer and chair of the board's finance committee.

She is a principal in the Law Offices of Carole Wagner Vallianos, a Manhattan Beach firm where she practices civil rights, nonprofit corporation law and estate planning. She was reappointed to the California Judicial Council's Standing Committee on Access and Fairness in the Courts and is a past member of the Jury Improvement Task Force and the Council's Advisory Committees on Race and Ethics Bias in the Courts and Private Judging.

Wagner Vallianos also is a Fellow of the California First Amendment Coalition and a former advisory board member of the Citizen Access Project, University of Florida's Brechner Center for Freedom of Information.

In addition, she is a member of Women Lawyers of Los Angeles, the South Bay Bar Association and the Benjamin Aranda III Inn of Court. She is past president of the League of Women Voters of California, and she was on the Board of Directors of the League of Women Voters of the United States and the Board of Trustees of the League of Women Voters Education Fund.

She has served as an NGO/nonprofit consultant with the U.S. Department of State in Bosnia, Turkey, Cyprus and India. She is a graduate of Coro, a public policy training program, and is a member of Pacific Council on International Policy. Wagner Vallianos received her B.A. from California State University, Fullerton, and her J.D. from Southwestern University School of Law.


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed President and CEO will be named president of the American Judicature Society
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
Breaking Medicine Technology: